Learn More
H eart transplantation (HT) has significantly altered the treatment paradigm for end-stage heart disease. With current surgical techniques and postoperative immunosup-pression, 1-year survival after HT is ≈90%, 5-year survival is ≈70%, and median survival exceeds 10 years. These improved outcomes have also affected the natural history of arrhythmia(More)
As companies increasingly customize their products, move towards smaller lot production and experiment with more flexible customer/supplier arrangements, they increasingly require the ability to respond quickly, accurately and competitively to customer requests for bids on new products and efficiently work out supplier/subcontractor arrangements for these(More)
  • 1